What is Generative Biology?
A primer on the emergence of one of the most exciting fields.
Generative biology is a rapidly emerging field that marries artificial intelligence and synthetic biology.
Combining these two fields has facilitated the creation of new biological entities — such as proteins. One of the most significant contributions to this field has been the development of transformer models. Transformer models are deep learning models that use attention mechanisms to understand protein sequences. These models have proven to be highly effective in generating natural language, and they are now being applied to biological systems to design and engineer proteins.
Protein Engineering
Proteins are workhorses carrying out many functions required for life. They comprise long chains of amino acids that fold into three-dimensional structures. These structures determine the protein's function and can be modified to create proteins with new properties. Protein engineering is designing and modifying proteins to achieve specific functions. This process involves identifying the amino acids critical for a protein's structure and function and altering them to create new properties.
Historically, protein engineering has been a time-consuming and labor-intensive process. Researchers would make small changes to the protein sequence and then test the resulting protein to see if it had the desired function. This process would be repeated many times until the desired function was achieved. However, with the emergence of generative biology, this process has become much faster and more efficient.
Transformer models have been used to design and engineer new proteins with specific functions. These models use a large amount of data to learn the relationship between the sequence of amino acids and the resulting protein structure and function. Once the model has learned these relationships, it can be used to generate new protein sequences with specific properties.
One of the most significant advances in protein engineering using transformer models has been the creation of AlphaFold. AlphaFold is a deep learning model developed by researchers at DeepMind, pioneers in artificial intelligence (AI) development and applications, that can predict the structure of proteins with high accuracy. This model uses attention mechanisms to understand the relationship between different protein sequence parts and predict the resulting structure. AlphaFold has been used to predict the structures of many previously difficult proteins to study, including membrane proteins and the nuclear pore complex.
Drug discovery and development
Discovering new drugs is notoriously slow, expensive, and challenging. It can take years or even decades for a potential drug candidate to make it from the lab to clinical trials. Even then, many promising compounds must meet safety and efficacy standards. Recent advances in AI and machine learning are also revolutionizing drug discovery, offering a powerful new tool for researchers to accelerate the discovery of new treatments and therapies.
AI-powered drug discovery is a rapidly growing field involving machine learning algorithms and other AI techniques to sift through vast data and identify promising drug candidates. This can include everything from genomic and proteomic data to information on chemical structures and drug targets. By analyzing this data with powerful AI algorithms, researchers can identify potential drug compounds and predict their effectiveness in treating a particular disease or condition.
One of the main advantages of using AI in drug discovery is that it can significantly speed up identifying potential drug candidates. Traditional drug discovery involves screening thousands or even millions of compounds in the lab, which is time-consuming and resource-intensive. With AI, researchers can rapidly analyze massive amounts of data and identify the most promising candidates for further testing.
AI can also help to optimize the drug discovery process by predicting the optimal dosages, formulations, and delivery methods for a particular drug candidate. This can help to streamline clinical trials and reduce the risk of adverse reactions or side effects.
There are already several examples of AI-powered drug discovery in action. For example, the biotech company Insitro uses AI to identify potential drug targets for human diseases. Another example is the startup Atomwise, which uses AI to screen potential drug compounds for combating diseases. The company’s AI-powered platform can analyze millions of potential drug compounds in just a few hours, significantly speeding up drug discovery.
Despite the promise of AI in drug discovery, there are also some challenges and limitations to be aware of. One major concern is the potential for bias in AI algorithms, which could lead to inaccurate predictions or skewed results. It’s also important to ensure that any new drugs discovered using AI are safe and effective and don’t pose any patient risks.
Nevertheless, the potential benefits of AI in drug discovery are enormous, and the field is likely to continue to grow and evolve in the coming years. By harnessing the power of machine learning and other AI techniques, researchers have the potential to accelerate the discovery of new treatments and therapies and ultimately improve the lives of millions of people around the world.
An exciting future
The future of AI and biology is exciting and promising. The intersection of these two fields has the potential to transform the way we approach healthcare and medicine, including developing new treatments for diverse diseases. With the help of AI, we can unlock the secrets of biological systems and harness them for the betterment of humanity.
As AI continues to evolve and mature, we can expect even more breakthroughs and innovations in protein engineering, drug discovery, and other areas of biology. However, as with any emerging technology, there are also potential risks and ethical considerations to be aware of. It is essential to ensure that the development and application of these technologies are made responsibly and ethically, with the ultimate goal of improving human health and well-being. By balancing innovation with responsible stewardship, we can create a future in which AI and biology work together to unlock life's full potential.
Connect with Genomely!
Substack: Genomely from Jacob L. Steenwyk
Twitter: @Genomely
GitHub: GenomelyBio
Connect with me!
Twitter: @jlsteenwyk
Website: jlsteenwyk.com